Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis.
In non-small cell lung cancer (NSCLC), nodal metastasis is an adverse prognostic factor. Several mediating factors have been implied in the development of nodal metastases and investigated for predictive and prognostic properties in NSCLC. However, study results differ. In this structured review and...
Main Authors: | Thomas K Kilvaer, Erna-Elise Paulsen, Sigurd M Hald, Tom Wilsgaard, Roy M Bremnes, Lill-Tove Busund, Tom Donnem |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4549062?pdf=render |
Similar Items
-
CD45RO+ Memory T Lymphocytes — a Candidate Marker for TNM-Immunoscore in Squamous Non–Small Cell Lung Cancer
by: Erna-Elise Paulsen, et al.
Published: (2015-11-01) -
Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
by: Thomas K Kilvaer, et al.
Published: (2015-01-01) -
Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
by: Eivind Smeland, et al.
Published: (2012-01-01) -
Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival
by: Thomas Karsten Kilvaer, et al.
Published: (2010-01-01) -
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer.
by: Samer Al-Saad, et al.
Published: (2017-01-01)